Please wait while the formulary information is being retrieved.
WAL-FOUR (PHENYLEPHRINE HCL)
- Eustachian tube congestion
- Nasal congestion
- Rhinorrhea
- Wal-four Nasal Spray
- Sinus Relief (phenylephrine) Nasal Spray
- Nasal Four Spray
- Fast Acting Nasal Spray
- 4 Way Nasal Spray
1 % nasal spray
- Dosage information is not available
(phenylephrine) 1 % nasal spray
- Dosage information is not available
1 % spray
- Dosage information is not available
1 % spray
- Dosage information is not available
1 % nasal spray
- Dosage information is not available
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- linezolid
- methylergonovine
- Migergot
- Migranal
- Parlodel
- rasagiline
- selegiline HCl
- sevoflurane
- Sojourn
- Terrell
- Ultane
- Zelapar
- Zyvox
Severe
Moderate
- reserpine
- None
Contraindicated
- Benign prostatic hyperplasia
Severe
Moderate
- Cardiac disease
- Coronary artery disease
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
WAL-FOUR (PHENYLEPHRINE HCL)
- Eustachian tube congestion
- Nasal congestion
- Rhinorrhea
- None
- None
More Frequent
Severe
Less Severe
- Rebound nasal congestion
- Dry nose
- Nasal passage irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Cardiac arrhythmia
- Dizziness
- Headache disorder
- Hyperhidrosis
- Insomnia
- Nervousness
- Pallor
- Tachycardia
- Tremor
Less Severe
- None
Contraindicated
None
Severe Precaution
Phenylephrine (Nasal)
Risk of CNS excitation. Do not use age <6 years without clinician consult.
- 1 Day – 6 Years
- Risk of CNS excitation. Do not use age <6 years without clinician consult.
Management or Monitoring Precaution
None
Phenylephrine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Phenylephrine
Oral bioavailability low; infant exposure may be minimal
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Oral bioavailability low; infant exposure may be minimal |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Phenylephrine
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Eustachian tube congestion | |
| H69.80 | Other specified disorders of eustachian tube, unspecified ear |
| H69.81 | Other specified disorders of eustachian tube, right ear |
| H69.82 | Other specified disorders of eustachian tube, left ear |
| H69.83 | Other specified disorders of eustachian tube, bilateral |
| Nasal congestion | |
| R09.81 | Nasal congestion |
| Rhinorrhea | |
| R09.82 | Postnasal drip |
| 0-9 | A-Z |
|---|---|
| H69.80 | Other specified disorders of eustachian tube, unspecified ear |
| H69.81 | Other specified disorders of eustachian tube, right ear |
| H69.82 | Other specified disorders of eustachian tube, left ear |
| H69.83 | Other specified disorders of eustachian tube, bilateral |
| R09.81 | Nasal congestion |
| R09.82 | Postnasal drip |
Formulary Reference Tool